Form 4: Health In Tech Director Boosts Equity Stake

Health In Tech Director Sanjay K Shrestha reported an increase in beneficial ownership of Class A Common Stock through new restricted stock grants.

Summary

• Sanjay K Shrestha, a Director of Health In Tech, Inc. (HIT), reported changes in his beneficial ownership of Class A Common Stock.
• On October 3, 2025, 65,469 restricted shares of Class A Common Stock, granted under the Health in Tech Equity Incentive Plan, were forfeited due to the issuer's annual stockholders meeting.
• On October 8, 2025, Shrestha was granted 5,730 new restricted shares of Class A Common Stock at a price of $3.49 per share.
• These newly granted restricted shares vest quarterly, contingent on the reporting person's continuous service through the vesting date.
• Following these transactions, Shrestha beneficially owns a total of 68,735 shares, which includes 5,730 restricted shares and 63,005 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: Director Sanjay K Shrestha's beneficial ownership increased overall, driven by a new restricted stock grant, despite a prior forfeiture. This indicates continued alignment with the company's equity incentive plan and provides an ongoing incentive for continuous service.

Positives

• Director Sanjay K Shrestha received a new grant of 5,730 restricted shares, indicating continued alignment with company performance and long-term incentives.
• The new restricted shares vest quarterly, providing an ongoing incentive for continuous service and performance.

Negatives

• A forfeiture of 65,469 restricted shares occurred on October 3, 2025, which reduced the director's previous holdings.

Risks

• The vesting of the 5,730 new restricted shares is subject to the reporting person's continuous service, meaning the shares could be forfeited if service ceases.

Future Outlook

The newly granted restricted shares will vest quarterly, subject to the director's continuous service, providing future equity incentives and aligning interests with long-term company performance.

Industry Context

This insider transaction report is specific to Health In Tech, Inc. and its director, reflecting individual equity compensation and ownership changes rather than broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The director's increased beneficial ownership through equity grants aligns their interests more closely with those of shareholders.
• Employees: The Health in Tech Equity Incentive Plan serves as a mechanism for retaining and incentivizing key personnel, including directors.

Next Steps

• The 5,730 restricted shares granted on October 8, 2025, will vest quarterly, contingent on the director's continuous service.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to an equity incentive plan. While a director's increased beneficial ownership can be viewed as a positive signal of confidence, the filing alone does not provide sufficient fundamental or strategic information to warrant a 'buy' or 'sell' recommendation. It is a standard disclosure of changes in insider holdings.

Keywords

Health In Tech, HIT, Sanjay Shrestha, Form 4, Insider Trading, Restricted Stock, Equity Incentive Plan, Director Ownership